ILMN · Illumina Inc
Price
Snapshot
50 fields · last close| Market Cap | $33.47B |
| P/E | 39.20 |
| Float | 150.9M |
| Beta | 1.48 |
| Volatility | 37.1% |
| Exchange | NASDAQ |
| Sector | Life Sciences Tools & Services |
| Cap tier | Large cap |
| Macro sensitivity | High |
| Clavix score | 70 |
| Price | 217.92 |
| Change | −1.69% |
| Prev Close | 221.66 |
| Open | 213.24 |
| Day Low | 210.94 |
| Day High | 221.76 |
| Avg Vol | 2 |
| Avg $ Vol | $445.7M |
| 52W High | 231.81 |
| 52W Low | 88.00 |
| 52W Pos | 90.3% |
| From High | −5.99% |
| From Low | +147.64% |
| Max DD 1Y | −25.66% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +5.27% |
| SMA 50 | +10.42% |
| SMA 200 | +43.95% |
| RSI (14) | 61.7 |
| Vol 30D | 46.7% |
| Vol 90D | 43.3% |
| 1Y Range | 88–232 |
| Daily bars | 506 |
| Perf Week | −2.65% |
| Perf Month | +10.90% |
| Perf Quarter | +31.89% |
| Perf Half Y | +72.85% |
| Perf Year | +130.73% |
| Perf YTD | +62.20% |
| Prev Day | −1.69% |
| Clavix | B- |
| Debt / Eq | 0.73 |
| Curr Ratio | 2.08 |
| Int Cover | 11.0× |
| FCF Margin | 23.8% |
| Rev Growth | +9.4% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 9 / 19 |
Clavix risk grade
regraded every trading dayILMN grades B-, 70 of 100. Steadiest on Sector Resilience (67), most exposed on Price Stability (54, mixed). 1 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 9 of 19 in Life Sciences Tools & Services by Clavix score.
How rough the ride is
| ILMN | Life Sciences Tools & Services median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.48 | 1.19 |
| Volatilityannualized | 37.1% | 29.7% |
| Max drawdown, past yearworst peak-to-trough fall | −25.7% | — |
| Typical daily movemedian absolute daily change | 1.78% | — |
| Days beyond ±3%of the last 252 sessions | 5622% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| ILMN | Life Sciences Tools & Services median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.48 | 1.19 |
| Macro sensitivityrate, dollar and credit exposure bucket | High | Moderate47% of 19 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| ILMN | |
|---|---|
| 1 week | −2.6% |
| 1 month | +10.9% |
| Year to date | +62.2% |
| 1 year | +130.7% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| ILMN | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 30 Jul |
| Average score0 most bearish, 100 most bullish | 64 |
| Bullish · bearisharticles above 60 · below 40 | 19 · 4 |
| Directionarticles whose tone is improving vs worsening | 19 ↑ 4 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.
Growth
| ILMN | |
|---|---|
| Revenue growthyear over year | +9.4% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Life Sciences Tools & Services
19 companies| Metric | ILMN | Sector spread | Median |
|---|---|---|---|
| Beta | 1.48 | 1.19 | |
| Volatility | 37.1% | 29.7% | |
| P/E | 39.20 | 36.77 | |
| Debt / equity | 0.73 | 0.51 | |
| Current ratio | 2.08 | 1.89 | |
| FCF margin | 23.8% | 19.5% | |
| Interest coverage | 11.0× | 3.5× |
Recent news
most recent scored articles · the chip is the article’s score · click to openNo specific company event or new development is reported.
The article poses the question of whether to add Illumina stock to a portfolio, noting that growth in its sequencing business, progress in oncology, and expansion into multiomics support the outlook, while fluctuating costs could squeeze profit margins. No specific development or event is reported.
Legal & General Group Plc disclosed it bought a new position of 1,173,286 shares of Illumina during the second quarter, according to its most recent SEC filing. The article body is truncated and does not show the dollar value of the stake.
Bamco Inc. NY disclosed in a recent SEC filing that it bought a new position in Illumina during the second quarter, purchasing 227,094 shares worth about $39.93 million.
Illumina implemented SAP Transportation Management and SAP Business Network for Logistics to replace fragmented, email-based transportation planning for its temperature-sensitive genomic sequencing products. The company has since onboarded 15 to 20 bulk carriers electronically, allowing carriers to validate booking details and send confirmations digitally.
Nearest peers by size
Life Sciences Tools & Services| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| WAT | Waters Corp | B | $37.34B | 243.61 | 1.19 | Compare |
| MTD | Mettler-toledo International Inc | B+ | $27.17B | 29.97 | 1.21 | Compare |
| A | Agilent Technologies Inc | B | $42.28B | 29.65 | 1.27 | Compare |
| IQV | IQVIA Holdings Inc | B- | $44.71B | 32.10 | 1.18 | Compare |
| WST | West Pharmaceutical Services Inc | B+ | $23.90B | 42.69 | 1.16 | Compare |
| MEDP | Medpace Holdings Inc | B- | $16.56B | 33.64 | 1.13 | Compare |
| RVTY | Revvity Inc | B | $14.58B | 61.02 | 1.11 | Compare |
| CRL | Charles River Laboratories International Inc | B- | $14.00B | — | 1.40 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.